NEUROCUPLE™ in TKA Patients to Enhance Pain Management
Launched by NCAP MEDICAL · Jun 11, 2024
Trial Information
Current as of November 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new pain management device called NEUROCUPLE™ for patients undergoing total knee replacement surgery, also known as total knee arthroplasty (TKA). The goal is to see if wearing the NEUROCUPLE™ patch for 30 days can help reduce pain and the need for opioids, which are strong pain medications that can have side effects. Participants will be randomly assigned to either receive the active device or a similar-looking placebo device that does not have the pain-relieving features. This way, researchers can accurately measure how well the NEUROCUPLE™ works.
To join this study, participants need to be at least 18 years old and scheduled for their first knee replacement surgery. They should not have severe anxiety, depression, or other conditions that would make their recovery complicated. Throughout the trial, participants can expect regular check-ins to monitor their pain levels and overall recovery. It’s important to note that this study is currently recruiting participants, and it aims to provide valuable information that could lead to a new, effective way to manage pain after knee surgery without relying on opioids.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \>18 years of age
- • Scheduled for elective primary unilateral TKA
- • T-score \< 60 on the PROMIS Anxiety measure
- Exclusion Criteria:
- • Children (\<18 yr.)
- • Pregnant women
- • Active alcoholism (defined as daily use of more than 1 liter of wine and /or 3 or more shots of hard liquor) or drug abuse (defined as daily use of illicit drugs)
- • Severe chronic pain condition that requires daily preoperative opioid dependence
- • T-score ≥ 60 in any of the three PROMIS measures (i.e., sleep, anxiety, and depression)
- • Other concomitant surgery being performed in addition to TKA
- • Patients undergoing bilateral TKA
- • Patients undergoing knee replacement revision
- • Patients with limited mobility (in a wheelchair or requiring a walker)
- • Patients who are not returning home after surgery
About Ncap Medical
ncap medical is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a focus on enhancing patient outcomes, the organization specializes in designing and conducting rigorous clinical studies across various therapeutic areas. Committed to ethical practices and regulatory compliance, ncap medical collaborates with healthcare professionals, research institutions, and regulatory agencies to ensure the highest standards of quality and integrity in clinical trials. Their expertise and dedication to scientific excellence position ncap medical as a trusted partner in the pursuit of groundbreaking medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Jacques E. Chelly, MD, PhD, MBA
Principal Investigator
University of Pittsburgh / UPMC
Amy Monroe, MPH, MBA
Study Director
University of Pittsburgh / UPMC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported